Orlistat open ring amide impurity is a synthetic byproduct formed via hydrolytic cleavage of the tetrahydrotetralin lactone ring in orlistat, resulting in an open-chain amide structure. The compound retains the fluorinated phenyl ring and terminal carboxylic acid ester but features a linearized amide linkage between the cyclohexane and aromatic moieties. This structural modification introduces a free amide NH group, altering its polarity and chromatographic retention compared to the parent API. It serves as a critical HPLC reference standard for monitoring ring-opening degradation pathways in orlistat manufacturing processes.
On Request| Std | Catalog # | Quantity | Price |
|---|---|---|---|
| USP | 1A06880 โ | 25 mg | USD 1625.00 |
CCCCCCCCCCC[C@@H](C[C@@H]([C@H](CCCCCC)C(=O)O)O)OC(=O)[C@H](CC(C)C)NC=O
InChI=1S/C29H55NO6/c1-5-7-9-11-12-13-14-15-16-18-24(36-29(35)26(30-22-31)20-23(3)4)21-27(32)25(28(33)34)19-17-10-8-6-2/h22-27,32H,5-21H2,1-4H3,(H,30,31)(H,33,34)/t24-,25-,26-,27-/m0/s1
FKUNIADJSAJLGB-FWEHEUNISA-N